Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT02705105 · COMPLETED
Trial details
- NCT number
- NCT02705105
- Sponsor
- Kyowa Kirin, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2018-08-22
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.